Yonatan Keschner, Chief Executive Officer of ARC Landing Boston, Attending Physician, Emergency Medicine at Brigham and Women’s Hospital, shared on LinkedIn:
“We are proud to announce a new collaboration agreement between ARC Landing Boston and the Dana-Farber Cancer Institute, creating a framework to explore joint initiatives in oncology innovation, AI, and digital health.
‘This agreement marks an exciting new chapter for ARC Landing Boston as we continue building a collaborative ecosystem across Massachusetts and strengthen our local economy,‘ said Dr. Yonatan Keschner, MD, MHCM, CEO of ARC Landing Boston. ‘Working alongside Dana-Farber will help us connect promising global health technologies with one of the world’s premier cancer centers, creating new opportunities to validate, refine, and scale innovations that can benefit patients locally and around the world.’
‘Dana-Farber Cancer Institute sees this collaboration as an important opportunity to help shape the next generation of innovation in oncology,’ said Adam Reich, Senior Vice President, Business Strategy at DFCI ‘By exploring new models in digital health, AI, and clinical delivery, we can better evaluate how emerging solutions may support our strategic priorities in research, clinical care, and bring meaningful innovation to the communities we serve.’
When we launched ARC Landing Boston, the vision was never only to help startups enter the U.S. market. It was to build trusted bridges with leading health systems and create new pathways for innovation to move faster from promise to clinical impact.
This collaboration marks a major step toward that vision and strengthens our shared commitment to advancing healthcare innovation across the Commonwealth of Massachusetts.
Thank you to the teams at Dana-Farber and ARC Landing Boston!
One more step in building a truly global healthcare innovation ecosystem.”
To which Katya Losk, Senior Director, International Strategic Initiatives at Dana-Farber Cancer Institute, added:
“Delighted to announce the Memoranum of Understanding signed between Dana-Farber Cancer Institute and Sheba Medical Center, Tel Hashomer’s ARC Landing Boston to explore initiatives in AI, oncology delivery models, and digital health.
Together, we look forward to validate, refine, and scale innovations that can benefit patients across the globe.”
Read more: Sheba’s ARC Landing Boston signs collaboration agreement with Dana-Farber
Other articles AI and digital health on OncoDaily.